Reduced glyoxalase 1 activity in carotid artery plaques of nondiabetic patients with increased hemoglobin A1c level

Journal of Vascular Surgery

Volumn 64, Issue 4, 2016, Pages 990-994

  Peters, Andreas S ^a   Lercher, Marieluise ^a   Fleming, Thomas H ^a,b   Nawroth, Peter P ^a,b,c   Bischoff, Moritz S ^a   Dihlmann, Susanne ^a   Böckler, Dittmar ^a   Hakimi, Maani ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CENTER FOR DIABETES RESEARCH DZD   (Germany)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLYOXALASE; GLYOXALASE 1; HEMOGLOBIN A1C; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; GLO1 PROTEIN, HUMAN; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; LACTOYLGLUTATHIONE LYASE;

AGED; ARTICLE; CAROTID ATHEROSCLEROSIS; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; ERYTHROCYTE; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; ATHEROSCLEROTIC PLAQUE; BLOOD; CAROTID ARTERY; CAROTID ARTERY DISEASES; CAROTID ENDARTERECTOMY; CASE CONTROL STUDY; DOWN REGULATION; ENZYMOLOGY; MIDDLE AGED; PATHOLOGY; UPREGULATION;

AGED; BIOMARKERS; CAROTID ARTERIES; CAROTID ARTERY DISEASES; CASE-CONTROL STUDIES; DOWN-REGULATION; ENDARTERECTOMY, CAROTID; ERYTHROCYTES; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LACTOYLGLUTATHIONE LYASE; MALE; MIDDLE AGED; PLAQUE, ATHEROSCLEROTIC; UP-REGULATION;

EID: 84979738808     PISSN: 07415214     EISSN: 10976809     Source Type: Journal    
DOI: 10.1016/j.jvs.2016.04.025     Document Type: Article

References (17)

1. 1 Thompson, R.C., Allam, A.H., Lombardi, G.P., Wann, L.S., Sutherland, M.L., Sutherland, J.D., et al. Atherosclerosis across 4000 years of human history: the Horus study of four ancient populations. Lancet 381 (2013), 1211–1222.
2. 2 Hansson, G.K., Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352 (2005), 1685–1695.
3. 3 Peppa, M., Uribarri, J., Vlassara, H., The role of advanced glycation end products in the development of atherosclerosis. Curr Diab Rep 4 (2004), 31–36.
4. 4 Fleming, T., Nawroth, P.P., Reactive metabolites as a cause of late diabetic complications. Biochem Soc Trans 42 (2014), 439–442.
5. 5 Kirk, J.E., The glyoxalase I activity of arterial tissue in individuals of various ages. J Gerontol 15 (1960), 139–141.
6. 6 Peters, A.S., Hakimi, M., Vittas, S., Fleming, T.H., Nawroth, P.P., Bockler, D., et al. Gender difference in glyoxalase 1 activity of atherosclerotic carotid artery lesions. J Vasc Surg 62 (2015), 471–476.
7. 7 Selvin, E., Steffes, M.W., Zhu, H., Matsushita, K., Wagenknecht, L., Pankow, J., et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med 362 (2010), 800–811.
8. 1c as predictor of all-cause mortality in individuals at high risk of diabetes with normal glucose tolerance, identified by screening: a follow-up study of the Anglo-Danish-Dutch Study of Intensive Treatment in People with Screen-Detected Diabetes in Primary Care (ADDITION), Denmark. Diabetologia 53 (2010), 2328–2333.
9. 9 Haring, R., Baumeister, S.E., Lieb, W., von Sarnowski, B., Volzke, H., Felix, S.B., et al. Glycated hemoglobin as a marker of subclinical atherosclerosis and cardiac remodeling among non-diabetic adults from the general population. Diabetes Res Clin Pract 105 (2014), 416–423.
10. 10 Rahbar, S., The discovery of glycated hemoglobin: a major event in the study of nonenzymatic chemistry in biological systems. Ann N Y Acad Sci 1043 (2005), 9–19.
11. 11 Gao, Y., Wang, Y., Site-selective modifications of arginine residues in human hemoglobin induced by methylglyoxal. Biochemistry 45 (2006), 15654–15660.
12. 12 Fleming, T., Cuny, J., Nawroth, G., Djuric, Z., Humpert, P.M., Zeier, M., et al. Is diabetes an acquired disorder of reactive glucose metabolites and their intermediates?. Diabetologia 55 (2012), 1151–1155.
13. 13 Kender, Z., Fleming, T., Kopf, S., Torzsa, P., Grolmusz, V., Herzig, S., et al. Effect of metformin on methylglyoxal metabolism in patients with type 2 diabetes. Exp Clin Endocrinol Diabetes 122 (2014), 316–319.
14. 14 Birkenmeier, G., Stegemann, C., Hoffmann, R., Gunther, R., Huse, K., Birkemeyer, C., Posttranslational modification of human glyoxalase 1 indicates redox-dependent regulation. PLoS One, 5, 2010, e10399.
15. 15 Mitsumoto, A., Kim, K.R., Oshima, G., Kunimoto, M., Okawa, K., Iwamatsu, A., et al. Nitric oxide inactivates glyoxalase I in cooperation with glutathione. J Biochem 128 (2000), 647–654.
16. 16 Lee, D.Y., Chang, G.D., Methylglyoxal in cells elicits a negative feedback loop entailing transglutaminase 2 and glyoxalase 1. Redox Biol 2 (2014), 196–205.
17. 17 Wortmann, M., Peters, A.S., Hakimi, M., Bockler, D., Dihlmann, S., Glyoxalase, I., (Glo1) and its metabolites in vascular disease. Biochem Soc Trans 42 (2014), 528–533.